| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.79B | 33.93B | 31.41B | 28.74B | 25.23B | 15.13B |
| Gross Profit | 17.87B | 17.99B | 16.84B | 15.46B | 13.66B | 7.97B |
| EBITDA | 2.90B | 2.39B | 2.34B | 2.71B | 1.97B | 990.00M |
| Net Income | 1.08B | 623.00M | 476.00M | 1.25B | 796.00M | 301.00M |
Balance Sheet | ||||||
| Total Assets | 22.88B | 20.89B | 20.11B | 23.10B | 18.30B | 17.83B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.39B | 938.00M | 5.04B | 964.00M | 1.83B |
| Total Debt | 4.40B | 4.81B | 4.94B | 8.12B | 7.72B | 8.24B |
| Total Liabilities | 13.74B | 12.70B | 12.56B | 16.61B | 16.48B | 16.80B |
| Stockholders Equity | 9.13B | 8.20B | 7.55B | 6.48B | 1.82B | 1.03B |
Cash Flow | ||||||
| Free Cash Flow | 1.69B | 2.24B | 48.00M | 2.23B | 778.00M | 832.00M |
| Operating Cash Flow | 1.81B | 2.40B | 152.00M | 2.26B | 881.00M | 870.00M |
| Investing Cash Flow | -400.00M | -344.00M | -414.00M | -464.00M | -773.00M | -215.00M |
| Financing Cash Flow | -941.00M | -593.00M | -3.84B | 2.27B | -978.00M | -438.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥151.47B | 9.78 | ― | 2.66% | -4.09% | 57.12% | |
72 Outperform | ¥4.39B | 6.43 | ― | 2.79% | 5.85% | 31.22% | |
71 Outperform | ¥230.57B | 9.23 | ― | 3.90% | 1.23% | 11.14% | |
69 Neutral | ¥15.55B | 23.32 | ― | 2.41% | -4.23% | 19.24% | |
69 Neutral | ¥16.76B | 4.12 | ― | 2.71% | 0.41% | 285.08% | |
65 Neutral | ¥315.92B | 14.72 | 8.35% | 2.73% | 1.53% | 43.13% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |